Skip to main
University-wide Navigation

'Behind the Blue': Leading the Way on Alzheimer’s Research With Linda Van Eldik of the Sanders-Brown Center on Aging

On this episode of "Behind the Blue," Sanders-Brown Center on Aging Director Linda Van Eldik joins UK Public Relations and Strategic Communications' Hillary Smith to discuss the larger game plan of finding a cure for Alzheimer’s and dementia.

UK Study: Tobacco Marketing Exposure Linked to Community Vulnerability

A recent College of Medicine study found young adults from vulnerable communities are more likely to be exposed to tobacco marketing in their daily lives.

UK to Enroll Additional Children in Moderna Vaccine Trial

The University of Kentucky is a site for KidCOVE, a national trial by Moderna to test the safety and effectiveness of its COVID-19 vaccine in children. The vaccine may protect young children 6 months to those under 12 years of age if they come into contact with the SARS-CoV-2 virus. 

Study Suggests Personalized Medicine May be the Future of Alzheimer’s Disease Treatment

A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) suggests that genetics can influence response to Alzheimer’s disease pathology.

UK Study Highlights the Importance of Signaling Molecule in Obesity

Recent work from the University of Kentucky College of Medicine published in Cell Press discusses an essential signaling pathway that causes metabolic dysfunction including insulin resistance and obesity.

UK Research Identifies Gene Linked to Evolution of Limb Development

University of Kentucky College of Medicine researchers were part of a recently published study giving insight into how limb development evolved in vertebrates.

10 UK Doctoral, Postdoctoral Researchers Named SEC Emerging Scholars

The program provides professional development and networking opportunities for current doctoral students and postdoctoral researchers considering careers in higher education.

UK Study Shows Combination Therapy May Potentially Improve Ovarian Cancer Patient Outcomes

A recent study demonstrates that a combination of two drugs used together provides better than expected results, providing a promising treatment strategy for patients with recurrent ovarian cancer.

'Behind the Blue': Cardiovascular Health and Research With Alan Daugherty

This week’s episode of "Behind the Blue" features the director of the Saha Cardiovascular Research Center and chair of the UK Department of Physiology, Alan Daugherty.

‘Truly Remarkable’: Center for Muscle Biology Lives Up to Challenge During COVID-19

In January 2021, the Center for Muscle Biology (CMB) officially transferred from the UK College of Medicine to become a part of the UK College of Health Sciences.